News and updates

Stay informed with the latest breakthroughs in macular research, emerging treatments for sight loss, and inspiring stories from the people we support. Browse our most recent news and insights below—and sign up to our free monthly enewsletter to never miss an update.

Lady wearing bionic eye

Q&A - your questions answered on the PRIMA System clinical trial for dry AMD

Posted: Monday 20 October 2025

All you need to know following the published results of Science Corporation's clinical trial to treat patients with late-stage dry age-related macular degeneration (AMD).

Find out more

A female patient taking part in the PRIMA System clinical trial, using the device to read letters on a computer screen.

Revolutionary implant allows patients with dry AMD to read again

Posted: Monday 20 October 2025

A revolutionary new implant has restored some vision to patients with dry age-related macular degeneration (AMD), enabling them to read words and numbers, boosting hopes of a breakthrough treatment.

Find out more

A dark-haired, male researcher wearing white overalls which includes the Macular Society logo. He is using a plunger to transfer liquid into a pipette. The Macular Society Conference logo sits in the top left corner.

Macular Society conference shines light on developing treatments

Posted: Thursday 9 October 2025

Our annual Macular Disease Conference: Hope for the Future returned in September, highlighting the experiences of people living with macular disease, exploring the latest in treatments and offering practical and emotional support.

Find out more

Elena Schiff. A white woman with long dark hair and glasses. She is smiling.

Genetic counselling and how it helps you

Posted: Tuesday 2 September 2025

What role does genetics play in macular disease? And what is the role of a genetic counsellor? In a recent webinar, Eleanor Schiff, a genetic counsellor at Moorfields Eye Hospital, explained her role, why it’s important, and what families can expect if they decide to explore it.

Find out more

Drug Vial close up

How do clinical trials play an important role in research?

Posted: Thursday 7 August 2025

Clinical trials play a vital role in trialling the development of new treatments for conditions such as age-related macular degeneration (AMD) and diabetic macular oedema (DMO). But, how do they work? And, why is participation in these trials so important?

Find out more

Couple on tablet

Experts share latest developments in treatment for macular disease

Posted: Monday 4 August 2025

Groundbreaking research into Stargardt disease, the latest treatments for age-related macular degeneration (AMD), and understanding the emotional impact of vision loss are just some of the topics to be explored at this year’s Macular Disease Conference ‘Hope for the Future’.

Find out more

Pete Coffey, a white man in his 60s with grey hair and a beard wearing a brown suit jacket smiling and leaning against lab equipment

Tributes paid to pioneering eye researcher Professor Pete Coffey

Posted: Wednesday 2 July 2025

Tributes have been paid to one of the world’s top eye researchers, Professor Pete Coffey, who has sadly passed away after a long illness.

Find out more

Headshot of professor Paulo Stanga, a white male with grey hair, smiling, wearing a suit and looking at camera.

Volunteers needed to try new drug for late-stage dry AMD

Posted: Thursday 5 June 2025

A company developing a new treatment for late-stage dry age-related macular degeneration (AMD) is looking for volunteers in the UK to take part in a new trial.

Find out more

Drug Vial close up

How are new treatments developed?

Posted: Monday 28 April 2025

Developing new treatments for macular disease is a lengthy process involving many steps. From understanding the causes of a condition, to finding new treatments to test, and finally, going through the stages of clinical trials.

Find out more

Andrew Lotery using optometrist equipment. Andrew is wearing blue scrubs and glasses and has dark short hair.

Professor Andrew Lotery answers your questions

Posted: Wednesday 5 March 2025

Professor Andrew Lotery discusses the latest approved treatment for wet age-related macular degeneration (AMD), Lytenava and answers your frequently asked questions on treatments and research.

Find out more

Gene double helix

Gene therapy trial improves sight in blind toddlers

Posted: Tuesday 4 March 2025

Four toddlers born with a severe form of childhood blindness have experienced “life-changing improvements” to their sight after participating in an experimental gene therapy trial. 

Find out more

Drug Vial close up

Syfovre FAQs and next steps for dry AMD and geographic atrophy treatment

Posted: Thursday 30 January 2025

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) decision to reject the first potential treatment for geographic atrophy (GA), or late-stage age-related macular degeneration (AMD) is undoubtedly a disappointing one for those living with the condition. But, what does the decision mean? We answer your questions.

Find out more